MARKET INTRODUCTION
Oncolytic virus is a type of immunotherapy that uses viruses to infection and destruction of cancer cells. Infection by certain viruses has been implicated in the development of certain cancers. Recently, viruses have been used to attack and target tumor cells that are already formed in the human body. The new therapy presents promising approach in the treatment of various types of cancers.
MARKET DYNAMICS
The oncolytic virus immunotherapy market is driving due to the factors such as support from FDA and other regulatory authorities to ramp-up the research procedures and capabilities for development of viral therapies and increasing prevalence of cancer patients across the globe. In addition, development and launch of new and innovative biotechnology based therapies are likely to offer growth opportunities for market players.
MARKET SCOPE
The "Oncolytic Virus Immunotherapy Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of oncolytic virus immunotherapy market with detailed market segmentation by type and end user. The oncolytic virus immunotherapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in oncolytic virus immunotherapy market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The oncolytic virus immunotherapy market is segmented on the basis of virus type, route of administration and application. Based on virus type, the market is segmented as herpes simplex virus, vaccinia virus, adenovirus, reovirus, and others. On the basis of route of administration, the market is segmented into intratumoral and intravenous. Based on application, the market is segmented into melanoma, non-small cell lung cancer (NSCLC), pancreatic cancer, breast cancer, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the oncolytic virus immunotherapy market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The oncolytic virus immunotherapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting oncolytic virus immunotherapy market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the oncolytic virus immunotherapy market in these regions.
MARKET PLAYERS
The report covers key developments in the oncolytic virus immunotherapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from oncolytic virus immunotherapy market are anticipated to have lucrative growth opportunities in the future with the rising demand for oncolytic virus immunotherapy in the global market. Below mentioned is the list of few companies engaged in the oncolytic virus immunotherapy market.
The report also includes the profiles of key players in oncolytic virus immunotherapy market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Amgen, Inc.
- Merck KGaA
- Shanghai Sunway Biotech Co. Ltd.
- TILT Biotherapeutics
- Oncorus, Inc.
- Oncolys BioPharma, Inc.
- Sorrento Therapeutics, Inc.
- Oncolytics Biotech, Inc.
- SillaJen, Inc.
- Replimune Group
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. PUBLISHERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Oncolytic Virus Immunotherapy Market - By Virus Type
1.3.2 Oncolytic Virus Immunotherapy Market - By Route of Administration
1.3.3 Oncolytic Virus Immunotherapy Market - By Application
1.3.4 Oncolytic Virus Immunotherapy Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. ONCOLYTIC VIRUS IMMUNOTHERAPY - GLOBAL MARKET OVERVIEW
6.2. ONCOLYTIC VIRUS IMMUNOTHERAPY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET - REVENUE AND FORECASTS TO 2027 - VIRUS TYPE
7.1. OVERVIEW
7.2. VIRUS TYPE MARKET FORECASTS AND ANALYSIS
7.3. HERPES SIMPLEX VIRUS
7.3.1. Overview
7.3.2. Herpes Simplex Virus Market Forecast and Analysis
7.4. VACCINIA VIRUS
7.4.1. Overview
7.4.2. Vaccinia Virus Market Forecast and Analysis
7.5. ADENOVIRUS
7.5.1. Overview
7.5.2. Adenovirus Market Forecast and Analysis
7.6. REOVIRUS
7.6.1. Overview
7.6.2. Reovirus Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. INTRATUMORAL
8.3.1. Overview
8.3.2. Intratumoral Market Forecast and Analysis
8.4. INTRAVENOUS
8.4.1. Overview
8.4.2. Intravenous Market Forecast and Analysis
9. ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. MELANOMA
9.3.1. Overview
9.3.2. Melanoma Market Forecast and Analysis
9.4. NON-SMALL CELL LUNG CANCER (NSCLC)
9.4.1. Overview
9.4.2. Non-small Cell Lung Cancer (NSCLC) Market Forecast and Analysis
9.5. PANCREATIC CANCER
9.5.1. Overview
9.5.2. Pancreatic Cancer Market Forecast and Analysis
9.6. BREAST CANCER
9.6.1. Overview
9.6.2. Breast Cancer Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Oncolytic Virus Immunotherapy Market Overview
10.1.2 North America Oncolytic Virus Immunotherapy Market Forecasts and Analysis
10.1.3 North America Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Virus Type
10.1.4 North America Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Application
10.1.6 North America Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Countries
10.1.6.1 United States Oncolytic Virus Immunotherapy Market
10.1.6.1.1 United States Oncolytic Virus Immunotherapy Market by Virus Type
10.1.6.1.2 United States Oncolytic Virus Immunotherapy Market by Route of Administration
10.1.6.1.3 United States Oncolytic Virus Immunotherapy Market by Application
10.1.6.2 Canada Oncolytic Virus Immunotherapy Market
10.1.6.2.1 Canada Oncolytic Virus Immunotherapy Market by Virus Type
10.1.6.2.2 Canada Oncolytic Virus Immunotherapy Market by Route of Administration
10.1.6.2.3 Canada Oncolytic Virus Immunotherapy Market by Application
10.1.6.3 Mexico Oncolytic Virus Immunotherapy Market
10.1.6.3.1 Mexico Oncolytic Virus Immunotherapy Market by Virus Type
10.1.6.3.2 Mexico Oncolytic Virus Immunotherapy Market by Route of Administration
10.1.6.3.3 Mexico Oncolytic Virus Immunotherapy Market by Application
10.2. EUROPE
10.2.1 Europe Oncolytic Virus Immunotherapy Market Overview
10.2.2 Europe Oncolytic Virus Immunotherapy Market Forecasts and Analysis
10.2.3 Europe Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Virus Type
10.2.4 Europe Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Application
10.2.6 Europe Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Oncolytic Virus Immunotherapy Market
10.2.6.1.1 Germany Oncolytic Virus Immunotherapy Market by Virus Type
10.2.6.1.2 Germany Oncolytic Virus Immunotherapy Market by Route of Administration
10.2.6.1.3 Germany Oncolytic Virus Immunotherapy Market by Application
10.2.6.2 France Oncolytic Virus Immunotherapy Market
10.2.6.2.1 France Oncolytic Virus Immunotherapy Market by Virus Type
10.2.6.2.2 France Oncolytic Virus Immunotherapy Market by Route of Administration
10.2.6.2.3 France Oncolytic Virus Immunotherapy Market by Application
10.2.6.3 Italy Oncolytic Virus Immunotherapy Market
10.2.6.3.1 Italy Oncolytic Virus Immunotherapy Market by Virus Type
10.2.6.3.2 Italy Oncolytic Virus Immunotherapy Market by Route of Administration
10.2.6.3.3 Italy Oncolytic Virus Immunotherapy Market by Application
10.2.6.4 Spain Oncolytic Virus Immunotherapy Market
10.2.6.4.1 Spain Oncolytic Virus Immunotherapy Market by Virus Type
10.2.6.4.2 Spain Oncolytic Virus Immunotherapy Market by Route of Administration
10.2.6.4.3 Spain Oncolytic Virus Immunotherapy Market by Application
10.2.6.5 United Kingdom Oncolytic Virus Immunotherapy Market
10.2.6.5.1 United Kingdom Oncolytic Virus Immunotherapy Market by Virus Type
10.2.6.5.2 United Kingdom Oncolytic Virus Immunotherapy Market by Route of Administration
10.2.6.5.3 United Kingdom Oncolytic Virus Immunotherapy Market by Application
10.2.6.6 Rest of Europe Oncolytic Virus Immunotherapy Market
10.2.6.6.1 Rest of Europe Oncolytic Virus Immunotherapy Market by Virus Type
10.2.6.6.2 Rest of Europe Oncolytic Virus Immunotherapy Market by Route of Administration
10.2.6.6.3 Rest of Europe Oncolytic Virus Immunotherapy Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Oncolytic Virus Immunotherapy Market Overview
10.3.2 Asia-Pacific Oncolytic Virus Immunotherapy Market Forecasts and Analysis
10.3.3 Asia-Pacific Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Virus Type
10.3.4 Asia-Pacific Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Oncolytic Virus Immunotherapy Market
10.3.6.1.1 Australia Oncolytic Virus Immunotherapy Market by Virus Type
10.3.6.1.2 Australia Oncolytic Virus Immunotherapy Market by Route of Administration
10.3.6.1.3 Australia Oncolytic Virus Immunotherapy Market by Application
10.3.6.2 China Oncolytic Virus Immunotherapy Market
10.3.6.2.1 China Oncolytic Virus Immunotherapy Market by Virus Type
10.3.6.2.2 China Oncolytic Virus Immunotherapy Market by Route of Administration
10.3.6.2.3 China Oncolytic Virus Immunotherapy Market by Application
10.3.6.3 India Oncolytic Virus Immunotherapy Market
10.3.6.3.1 India Oncolytic Virus Immunotherapy Market by Virus Type
10.3.6.3.2 India Oncolytic Virus Immunotherapy Market by Route of Administration
10.3.6.3.3 India Oncolytic Virus Immunotherapy Market by Application
10.3.6.4 Japan Oncolytic Virus Immunotherapy Market
10.3.6.4.1 Japan Oncolytic Virus Immunotherapy Market by Virus Type
10.3.6.4.2 Japan Oncolytic Virus Immunotherapy Market by Route of Administration
10.3.6.4.3 Japan Oncolytic Virus Immunotherapy Market by Application
10.3.6.5 South Korea Oncolytic Virus Immunotherapy Market
10.3.6.5.1 South Korea Oncolytic Virus Immunotherapy Market by Virus Type
10.3.6.5.2 South Korea Oncolytic Virus Immunotherapy Market by Route of Administration
10.3.6.5.3 South Korea Oncolytic Virus Immunotherapy Market by Application
10.3.6.6 Rest of Asia-Pacific Oncolytic Virus Immunotherapy Market
10.3.6.6.1 Rest of Asia-Pacific Oncolytic Virus Immunotherapy Market by Virus Type
10.3.6.6.2 Rest of Asia-Pacific Oncolytic Virus Immunotherapy Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Oncolytic Virus Immunotherapy Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Oncolytic Virus Immunotherapy Market Overview
10.4.2 Middle East and Africa Oncolytic Virus Immunotherapy Market Forecasts and Analysis
10.4.3 Middle East and Africa Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Virus Type
10.4.4 Middle East and Africa Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Oncolytic Virus Immunotherapy Market
10.4.6.1.1 South Africa Oncolytic Virus Immunotherapy Market by Virus Type
10.4.6.1.2 South Africa Oncolytic Virus Immunotherapy Market by Route of Administration
10.4.6.1.3 South Africa Oncolytic Virus Immunotherapy Market by Application
10.4.6.2 Saudi Arabia Oncolytic Virus Immunotherapy Market
10.4.6.2.1 Saudi Arabia Oncolytic Virus Immunotherapy Market by Virus Type
10.4.6.2.2 Saudi Arabia Oncolytic Virus Immunotherapy Market by Route of Administration
10.4.6.2.3 Saudi Arabia Oncolytic Virus Immunotherapy Market by Application
10.4.6.3 U.A.E Oncolytic Virus Immunotherapy Market
10.4.6.3.1 U.A.E Oncolytic Virus Immunotherapy Market by Virus Type
10.4.6.3.2 U.A.E Oncolytic Virus Immunotherapy Market by Route of Administration
10.4.6.3.3 U.A.E Oncolytic Virus Immunotherapy Market by Application
10.4.6.4 Rest of Middle East and Africa Oncolytic Virus Immunotherapy Market
10.4.6.4.1 Rest of Middle East and Africa Oncolytic Virus Immunotherapy Market by Virus Type
10.4.6.4.2 Rest of Middle East and Africa Oncolytic Virus Immunotherapy Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Oncolytic Virus Immunotherapy Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Oncolytic Virus Immunotherapy Market Overview
10.5.2 South and Central America Oncolytic Virus Immunotherapy Market Forecasts and Analysis
10.5.3 South and Central America Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Virus Type
10.5.4 South and Central America Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Application
10.5.6 South and Central America Oncolytic Virus Immunotherapy Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Oncolytic Virus Immunotherapy Market
10.5.6.1.1 Brazil Oncolytic Virus Immunotherapy Market by Virus Type
10.5.6.1.2 Brazil Oncolytic Virus Immunotherapy Market by Route of Administration
10.5.6.1.3 Brazil Oncolytic Virus Immunotherapy Market by Application
10.5.6.2 Argentina Oncolytic Virus Immunotherapy Market
10.5.6.2.1 Argentina Oncolytic Virus Immunotherapy Market by Virus Type
10.5.6.2.2 Argentina Oncolytic Virus Immunotherapy Market by Route of Administration
10.5.6.2.3 Argentina Oncolytic Virus Immunotherapy Market by Application
10.5.6.3 Rest of South and Central America Oncolytic Virus Immunotherapy Market
10.5.6.3.1 Rest of South and Central America Oncolytic Virus Immunotherapy Market by Virus Type
10.5.6.3.2 Rest of South and Central America Oncolytic Virus Immunotherapy Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Oncolytic Virus Immunotherapy Market by Application
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET, KEY COMPANY PROFILES
13.1. AMGEN, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. MERCK KGAA
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. SHANGHAI SUNWAY BIOTECH CO. LTD.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. TILT BIOTHERAPEUTICS
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ONCORUS, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ONCOLYS BIOPHARMA, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. SORRENTO THERAPEUTICS, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ONCOLYTICS BIOTECH, INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SILLAJEN, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. REPLIMUNE GROUP
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT PUBLISHERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. Amgen, Inc.
2. Merck KGaA
3. Shanghai Sunway Biotech Co. Ltd.
4. TILT Biotherapeutics
5. Oncorus, Inc.
6. Oncolys BioPharma, Inc.
7. Sorrento Therapeutics, Inc.
8. Oncolytics Biotech, Inc.
9. SillaJen, Inc.
10. Replimune Group